BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7287207)

  • 1. Long-term experience with Burkitt's lymphoma in Uganda.
    Olweny CL; Katongole-Mbidde E; Otim D; Lwanga SK; Magrath IT; Ziegler JL
    Int J Cancer; 1980 Sep; 26(3):261-6. PubMed ID: 7287207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience.
    Ziegler JL
    N Engl J Med; 1977 Jul; 297(2):75-80. PubMed ID: 865579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
    Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ
    Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study of 40 children with Burkitt's and Burkitt-like lymphoma].
    Zhang YH; Duan YL; Yang J; Jin L; Zhou CJ; Gao ZF
    Zhonghua Er Ke Za Zhi; 2008 Mar; 46(3):209-14. PubMed ID: 19099711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age and sex as factors influencing remission duration in African Burkitt's lymphoma.
    Biggar RJ; Gail MH; Banks RB; Neequaye J; Nkrumah FK
    Am J Epidemiol; 1982 Oct; 116(4):668-77. PubMed ID: 7137153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of Burkitt's lymphoma patients in Ghana.
    Wosornu JL; Nkrumah FK; Perkins IV
    Br J Cancer; 1971 Sep; 25(3):479-86. PubMed ID: 5144522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Maxillofacial location of Burkitt's lymphoma in children treated at the University Hospital Center in Bamako, Mali: a 24-case series].
    Togo B; Keita M; Medefo D; Traore F; Sidibe T
    Med Trop (Mars); 2008 Dec; 68(6):600-2. PubMed ID: 19639827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine.
    Murphy SB; Bowman WP; Abromowitch M; Mirro J; Ochs J; Rivera G; Pui CH; Fairclough D; Berard CW
    J Clin Oncol; 1986 Dec; 4(12):1732-9. PubMed ID: 3491184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of treatment of Burkitt's lymphoma patients in the West Nile District of Uganda at Kuluva Hospital.
    Williams EH; Breslow NE; Edlestein R
    East Afr Med J; 1982 Dec; 59(12):785-92. PubMed ID: 7184758
    [No Abstract]   [Full Text] [Related]  

  • 10. Jaw involvement in American Burkitt's Lymphoma.
    Sariban E; Donahue A; Magrath IT
    Cancer; 1984 Apr; 53(8):1777-82. PubMed ID: 6697316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HiC-COM: a 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia.
    Schwenn MR; Blattner SR; Lynch E; Weinstein HJ
    J Clin Oncol; 1991 Jan; 9(1):133-8. PubMed ID: 1985162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive chemotherapy for non-localised Burkitt's lymphoma.
    Al-Attar A; Pritchard J; Al-Saleem T; Al-Naimi M; Alash N; Attra A
    Arch Dis Child; 1986 Oct; 61(10):1013-9. PubMed ID: 3777984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of Burkitt's lymphoma patients in Mulago Hospital, Uganda.
    Morrow RH; Pike MC; Kisuule A
    Br Med J; 1967 Nov; 4(5575):323-7. PubMed ID: 6053614
    [No Abstract]   [Full Text] [Related]  

  • 14. Massive therapy and autologous bone marrow transplantation in very bad prognosis Burkitt's lymphoma.
    Philip T; Biron P; Philip I; Favrot M; Souillet G; Philippe N; Hervé P; Plouvier E; Bernard JL; Raybaud C
    IARC Sci Publ; 1985; (60):419-34. PubMed ID: 3905593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy for Burkitt's lymphoma according to the BL-M-04 protocol: 12-year experience].
    Baryakh EA; Tyurina NG; Vorobyev VI; Gemdzhyan EG; Mangasarova YK; Klyasova GA; Kovrigina AM; Obukhova TN; Zvonkov EE; Vernyuk MA; Chervontseva AM; Polyakov YY; Misyurina АЕ; Valiev TT; Zherebtsova VA; Magomedova AU; Galstyan GM; Yatskov KV; Nesterova ES; Vorobyev AI; Kravchenko SK
    Ter Arkh; 2015; 87(7):4-14. PubMed ID: 26390720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of moderate dose combination chemotherapy in Burkitt's lymphoma.
    Patel JG; Pandita R; al-Jazzaf H; Mechl Z; al-Jarallah MA
    Neoplasma; 1993; 40(3):185-8. PubMed ID: 8350967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy in abdominal Burkitt's lymphoma.
    Nkrumah FK; Perkins IV; Biggar RJ
    Cancer; 1977 Oct; 40(4):1410-6. PubMed ID: 907960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Burkitt's lymphoma: a clinicopathologic study of 30 cases. I. Clinical factors relating to prolonged survival.
    Arseneau JC; Canellos GP; Banks PM; Berard CW; Gralnick HR; DeVita VT
    Am J Med; 1975 Mar; 58(3):314-21. PubMed ID: 1115074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggressive chemotherapy in the treatment of Burkitt's and non-Burkitt's undifferentiated lymphoma.
    Mazza JJ; Hines JD; Andersen JW; Neiman RS; Mann R; Oken MM; O'Connell MJ
    Leuk Lymphoma; 1995 Jul; 18(3-4):289-96. PubMed ID: 8535195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cure of Burkitt's lymphoma.
    Med J Aust; 1980 Mar; 1(6):250-1. PubMed ID: 7374582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.